LIVER TRANSPLANTATION
Generic Name
Brand Name
Type
Antigenic Target
Initial
Approval
Likelihood
Score†
Major Uses
Basiliximab
Simulect
Chimeric
IL-2Rα
1998EPrevention of transplant rejection
Daclizumab
Zenapax
Humanized
IL-2
1997
Withdrawn
CPrevention of transplant rejection
Muromonab-CD3
OKT3
Mouse
CD3 T cells
1985

Withdrawn

EPrevention of transplant rejection

From: Monoclonal Antibodies

Cover of LiverTox
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.